BIRD-GLOBAL-INC
2.3.2022 15:03:23 CET | Business Wire | Press release
Bird Global, Inc. (NYSE:BRDS), a leader in environmentally friendly electric transportation, today announced availability of its custom designed and engineered e-bike, the Bird Bike throughout the UK. The Bird Bike is now available through its exclusive launch-partner, the UK’s largest cycling retailer Halfords via birdbike.co.uk .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220302005579/en/
Bird Bike was expertly designed by Bird’s in-house team of aerospace, automotive and micromobility engineers for a smooth and powerful ride. Its best-in-class safety features include a 250w Bafang rear hub motor, up to 25km/h speed assist, up to 100km range, 7-speed Shimano drivetrain for extra power on tough UK inclines, integrated LED lights, and a backlit handlebar dash display. Available in three colourways, Stealth Black, Gravity Grey and Starling Blue, the Bird Bike also connects via Bluetooth to the Bird app for added security alarm and battery controls.
The arrival of Bird Bike taps into a zeitgeist moment for e-bikes in the UK, with over 2.4 million online searches for ‘Electric Bike’ carried out last year and nearly 40% of UK residents saying they would cycle significantly more if they had one. E-bike demand continues to soar, with the total number of e-bikes in circulation expected to reach 300 million worldwide by 2023, a 50% increase over 20191 .
“The UK is investing heavily in its cycling infrastructure and people are now looking to micro-electric vehicles to replace their petrol-powered trips. The Bird Bike not only offers both new and experienced cyclists the thrill of the ride, but also the safety and technology synonymous with our brand,” said Brian Buccella, Senior Vice President, Government Partnerships and Consumer Products at Bird. “We are incredibly proud to partner with Halfords to launch Bird Bike in the UK. Their dedication to electric transportation and delivering high quality service, both instore and online, aligns perfectly with our values at Bird.”
Priced at £1,999, Bird Bike comes in two models: the step-over ‘A-Frame’, which is available now, and the step-through ‘V-Frame’, set to follow this summer. Orders can be made via the Halfords website and in-store teams will assemble the bike ready for collection.
"We are thrilled to be the exclusive launch partner for the Bird Bike in the UK, which will be available online at Halfords,” Rebecca Blewitt – Buyer for Electric Bikes, Halfords. “The new bike is such an innovative design and we can't wait for our customers to get their hands on one!"
Halfords is the UK's leading provider of motoring and cycling products and services. Customers who have purchased a Bird Bike via Halfords can experience a number of service benefits through the exclusive launch partnership. This includes one of Halfords’ 3000+ technicians taking the hassle out of building a bike by assembling it for customers, safety checks to ensure it’s ready to ride, and the ability to order a Bird Bike and have it delivered to one of Halfords' 404 stores.
For additional information visit: https://birdbike.co.uk/
About Bird Bike:
As part of its mission to enable access to eco-friendly mobility options for all, Bird's consumer e-bike is custom designed by Bird's in-house team of award winning engineers and industrial designers who brought to market the Bird Three, the industry's most eco-conscious shared e-scooter. Bird Bike's features designed to bring fun, safety and reliability include:
- Max electric assist speed of 25 kmph for efficient trips
- Bafang rear hub motor makes commuting an effortless breeze
- Safety certified and IP65+ water resistance increases security and safety
- Easy-to-read LCD panel displays speed, distance and battery capacity
- Kenda Kwick K Shield+ puncture-resistant tires minimise the likelihood of a flat
- Shimano’s Tourney 7 Speed & RapidFire Plus Shift provide flexible gear changes
- Integrated, high-visibility LED Lights ensure 180° visibility any time of day or night
- 346 Wh / 36 volt removable battery, powered by LG cells delivers up to 100km of electric range
- Front and rear Tektro disc brakes assures stopping power
- Fully adjustable seat height ensures comfort on the road
- Bluetooth connectivity with the Bird app helps Bird Bike owners easily turn on and off vehicle lights, view battery range and miles ridden
For more images, please see here .
About Bird
Bird is an electric vehicle company dedicated to bringing affordable, environmentally friendly transportation solutions such as e-scooters and e-bikes to communities across the world. Founded in 2017 by transportation pioneer Travis VanderZanden, Bird is rapidly expanding. Today, it provides fleets of shared micro electric vehicles to riders in more than 350 cities globally and makes its products available for purchase at www.bird.co and via leading retailers and distribution partners. Bird partners closely with the cities in which it operates to provide a reliable and affordable transportation option for people who live and work there.
1 All data via https://www.tredz.co.uk/research/e-bike-stats-2021
View source version on businesswire.com: https://www.businesswire.com/news/home/20220302005579/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom